Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

More people are seeing dermatologists for hair and scalp problems now than in the past.

Data mining helps identify and address nutrition deficiencies affecting health.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

A woman with lymphoma had a rare skin rash on her scalp and forehead, which was hard to diagnose but responded well to treatment.

The occipital scalp is affected in advanced hair loss, so it shouldn't be used as a control.

5-alpha reductase inhibitors slightly increase depression risk, but the risk varies based on the control group used.

Stressful life events may trigger alopecia areata.

Youth in Kashmir Valley, India, are likely to experience depression due to conflict and stressful conditions.

Urinary stones increased in Wuwei, China, especially in males, suggesting the need for better screening and healthcare.

Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.

High-quality data on skin cancer is crucial for understanding its trends and allocating healthcare resources effectively.

Skin treatment can lower life quality for patients with skin conditions.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

Africa needs its own dermatology guidelines to address unique skin challenges and improve care.

The pandemic caused new skin problems in children, mainly due to mask-wearing and stress.

Early diagnosis and treatment can lessen the impact of cicatricial alopecia.

People with alopecia areata in German-speaking countries spend a lot on their condition, with hair products and treatments being the most costly.

Alopecia areata costs individuals about 3% of their income, with women, Asians, those with lower income, and more severe symptoms spending more.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

Diseases have a big social impact in Nordic countries, affecting healthcare decisions.

Skin diseases affect young adults in India physically and emotionally.

The document concludes that terbinafine is effective for treating scalp fungal infections in children and recommends not excluding them from school during treatment, while also highlighting the need for updated treatment guidelines due to changing infection patterns.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.

Men with CCCA often face delayed diagnosis and severe hair loss, highlighting the need for earlier recognition and treatment.

A new treatment plan for alopecia areata considers disease severity, quality of life, and progression to offer personalized care.

Graves' disease can cause hair loss in children and should be considered when treating pediatric alopecia areata.